Scientists have a new tool for unraveling the mysteries of how diseases such as HIV move through a population, thanks to insights into phylogenetics, the creation of an organism’s genetic tree and evolutionary relationships.
Humabs BioMed SA and the Institute for Research in Biomedicine (IRB) affiliated to the Università della Svizzera italiana announced the identification, isolation and characterization of two Ebola virus neutralizing monoclonal antibodies from the blood of a survivor of an Ebola infection.
The Zika virus, unlike other mosquito-borne viruses such as dengue, is relatively unknown and unstudied. That is set to change since Zika, now spreading through Latin America and the Caribbean, has been associated with an alarming rise in babies born in Brazil with abnormally small heads and brain defects – a condition called microcephaly.
There may be a “silver bullet” for Ebola. Researchers at Vanderbilt University Medical Center and the University of Texas Medical Branch in Galveston (UTMB) reported that they have isolated human monoclonal antibodies from Ebola survivors which can neutralize multiple species of the virus.
Since 2012, at least 1,500 individuals have developed Middle East respiratory syndrome (MERS), resulting in more than 500 fatalities. Only now are results being reported of the first autopsy of a MERS patient, which was performed in 2014. Not only do these findings, published in The American Journal of Pathology, provide unprecedented, clinically-relevant insights about how MERS progresses, they…
When the Ebola virus outbreak erupted in West Africa in 2014, children infected with the virus — particularly those under age 5 — faced overwhelming challenges. Not only was there a high death rate among young children infected with the disease, they often were isolated from their families, leaving them feeling distressed and without the intensive care they needed.
Nothing could be simpler: a drop of blood is placed on a special carrier substance; after a wait of a few minutes, the slide is placed on a device that emits polarised light thanks to an inexpensive polarisation filter. It is covered with a lid containing a second polarisation filter, which blocks the light from all materials except crystalline or materials with directional properties.
A new report gives the first ever picture of global investment in Ebola research and development (R&D), reporting that this investment might have come at the expense of efforts to develop drugs, vaccines and diagnostics for other neglected diseases, which collectively cause more than six million deaths every year in developing countries.
A banana a day may not keep the doctor away, but a substance originally found in bananas and carefully edited by scientists could someday fight off a wide range of viruses, new research suggests. And the process used to create the virus-fighting form may help scientists develop even more drugs, by harnessing the “sugar code” that our cells use to communicate. That code gets hijacked by…
Bacteria aren’t the only nonhuman invaders to colonize the gut shortly after a baby’s birth. Viruses also set up house there, according to new research at Washington University School of Medicine in St. Louis. All together, these invisible residents are thought to play important roles in human health.
It’s a race against the clock; every hour counts in efforts to halt the spread of a disease, but identifying anyone with whom the infected patient has had contact is time-consuming, with Contact Officers generally collecting data on paper. Now, however, scientists from the Nigerian Field Epidemiology Laboratory & Training Programme, the Helmholtz Centre for Infection Research, the Hasso…
The District of Columbia's needle exchange program prevented 120 new cases of HIV infection and saved an estimated $44 million over just a two-year period, according to a first-of-a-kind study published today by researchers at the Milken Institute School of Public Health (Milken Institute SPH) at the George Washington University.
Working as part of an international team in the United States and West Africa, a researcher at The Scripps Research Institute (TSRI) has published new findings showing the ancient roots of the deadly Lassa virus, a relative of Ebola virus, and how Lassa virus has changed over time.
As the Ebola virus disease pandemic unfolded in 2014, it may have seemed like a sudden and unprecedented event. But the disease has a long history, the epidemic is ongoing, and new outbreaks are certain to occur in the future, reports the September issue of Anesthesia & Analgesia.
An LMU team has uncovered a new role for the protein Atrx, which is involved in various aspects of gene expression. The new work shows that the protein is also involved in silencing endogenous retroviral genomes integrated in cellular DNA.
Ebola is a preventable disease, and yet a safe and effective vaccine has not been deployed. As with many vaccines, financial barriers persist: pharmaceutical companies see high costs with limited market potential, and government support is lacking. But there may be a solution to this vaccine crisis with the ability to save at-risk populations, according to a perspective piece written by…
Research presented at the 2015 AACC Annual Meeting & Clinical Lab Expo will expand on the studies that led to a fingerprick Ebola test becoming the first and only rapid diagnostic for this disease to receive approval from the World Health Organization (WHO). This test could prove vital to breaking Ebola’s grip on West Africa by identifying suspected Ebola cases within minutes, and enabling…
The ESCMID Study Group for Forensic and Postmortem Microbiology will create a new network of microbiologists, virologists, anthropologists and archaeologists working in the field of forensic medicine. Professor Amparo Fernandez-Rodriguez, from the National Institute of Toxicology and Forensic Sciences, Madrid, is the head of ESGFOR and stresses the importance of this group in facilitating…
The International Council of Nurses (ICN) reissued its call for increased support of and safer working environments for nurses and other healthcare workers on the frontlines of healthcare. The call follows a preliminary report issued by the World Health Organization which states that of the 815 healthcare workers who have been infected by the Ebola virus since the onset of the epidemic, more…
LMU researchers demonstrate for the first time that bacteriophages (bacterial viruses) carry genetic instructions for proteins that mediate the transport of their DNA to specialized replication sites in the host cell.
The European Society of Clinical Microbiology and Infectious Disease (ESCMID) today issued a special excellence award for outstanding achievement to Médecins Sans Frontières (MSF). The award was bestowed in Copenhagen at ESCMID’s annual congress, on behalf of all its members, in light of the charity’s huge contribution to global health over the last 40-years, and in special recognition of…
In European acute care hospitals, on any given day, an estimated 80,000 patients – roughly six percent of all patients – receive antimicrobial treatment to fight a healthcare associated infection (HAI), according to the European Centre for Disease Prevention and Control (ECDC). Report: Walter Depner
A newly launched test enables the quantitative determination of PCT in serum samples, EDTA or lithium heparin plasma samples by latex enhanced immunoturbidimetric methodology. The Stanbio Chemistry Procalcitonin (PCT) LiquiColor Assay was launched by EKF Diagnostics, based in Cardiff, Wales, which explains: ‘Procalcitonin is a marker for bacterial infection and sepsis and has been recognised as…
Dr Ahmed Abd El Wahed, research associate in the Department of Infection Models at the German Primate Centre (DPZ) in Göttingen, has developed a portable laboratory for fast diagnosis of Ebola. The new procedure is six to ten times faster than the one currently used, and equally sensitive. Report: Anja Behringer
The ‘Robert Koch’ plane for medical evacuations (MedEvac) is the winged equivalent of a German hospital isolation ward. Within it, medics with viral haemorrhagic fever while working on the Ebola outbreak in West Africa, receive intensive medical care during any stages of the disease, while being evacuated. Report: Anja Behringer
